Decoy Therapeutics Inc.
Cash Flow History
| Period | Operating Cash Flow | Free Cash Flow | CapEx | Share-Based Compensation |
|---|---|---|---|---|
| Mar 2015 | $-4.1M | $-4.2M | $26.4K | $1.7M |
| Jun 2015 | $-4.5M | $-4.5M | $49.2K | — |
| Sep 2015 | $-6.7M | $-6.9M | $147.7K | — |
| Mar 2016 | $-9.2M | $-9.3M | $107.3K | $1.5M |
| Jun 2016 | $-9.3M | $-9.5M | $182.9K | — |
| Sep 2016 | $-7.3M | $-7.5M | $218.8K | — |
| Mar 2017 | $-8.2M | $-8.2M | $22.2K | $1.2M |
| Jun 2017 | $-5.7M | $-5.7M | $31.6K | — |
| Sep 2017 | $-8.1M | $-8.1M | $44.4K | — |
| Mar 2018 | $-9.4M | $-9.4M | $0 | $908.9K |
| Jun 2018 | $-8.3M | $-8.3M | $0 | — |
| Sep 2018 | $21.5M | $21.5M | $0 | — |
| Mar 2019 | $-1.9M | $-1.9M | — | $35.4K |
| Jun 2019 | $-1.5M | $-1.5M | — | — |
| Sep 2019 | $-5.5M | $-5.5M | — | — |
| Mar 2020 | $-3.7M | $-3.7M | — | $38.4K |
| Jun 2020 | $-2.5M | $-2.5M | — | — |
| Sep 2020 | $-2.8M | $-2.8M | — | — |
| Mar 2021 | $-2.7M | $-2.7M | — | $135.4K |
| Jun 2021 | $-3.2M | $-3.2M | — | — |
| Sep 2021 | $-1.6M | $-1.6M | — | — |
| Mar 2022 | $-3.5M | $-3.5M | — | $313.9K |
| Jun 2022 | $-3.6M | $-3.6M | — | — |
| Sep 2022 | $-5.7M | $-5.7M | — | — |
| Mar 2023 | $-3.2M | $-3.2M | — | $203.3K |
| Jun 2023 | $-4.4M | $-4.4M | — | — |
| Sep 2023 | $-3.7M | $-3.7M | — | — |
| Mar 2024 | $-1.4M | $-1.4M | — | $77.5K |
| Jun 2024 | $-1.1M | $-1.1M | — | — |
| Sep 2024 | $-1.4M | $-1.4M | — | — |
| Mar 2025 | $-1.2M | $-1.2M | — | $33.5K |
| Jun 2025 | $-862.3K | $-862.3K | — | — |
| Sep 2025 | $-1.6M | $-1.6M | — | — |
| Mar 2026 | $-2.9M | $-2.9M | — | $213.0K |
| Jun 2026 | $-2.7M | $-2.7M | — | — |